What’s Driving the December 2025 Move and What Comes Next
Edgewise Therapeutics, Inc. (NASDAQ: EWTX) is back in the spotlight heading into December 20, 2025—not because of a single blockbuster headline, but because the stock just posted a sharp, high-volume move that traders and long-term biotech investors both tend to notice.
With Edgewise still a clinical-stage company, the share price often reflects a shifting mix of (1) expectations for clinical readouts, (2) perceived regulatory timelines, and (3) sentiment in the biotech tape. In other words: EWTX can move fast—even when the company itself hasn’t issued fresh news in the last 24–48 hours.
Below is a comprehensive look at the latest price action, verified company updates, and the freshest available analyst forecasts and technical…
